Merck Defends Vioxx Strategy, Releases Arcoxia Data
Company faces two Vioxx setbacks in court as it prepares to reveal safety data on its cox-2 successor.
Federal Courts Get Tough on Patents
Recent analysis shows partial or complete invalidation of all pharma patents challenged since December 2004.
Nasonex Bee Buzzes New Message
Schering-Plough's successful allergy medication gets an updated ad campaign.
